Research has demonstrated the important role of effective primary care in illness prevention and earlier – and less costly – disease interventions. This certainly applies to chronic conditions like hypertension, diabetes, and mental illness, which drive more than 85% of healthcare cost. Though in the US there are currently proportionally fewer primary care physicians than other industrialized nations, and patients visit their primary care physician less frequently than in other countries, primary care must play a key role in the successful expansion of healthcare coverage. Strong primary care has been shown to increase medication adherence, reduce hospitalizations, and improve hard metrics such as cholesterol and HgbA1C.
While primary care physicians often are drawn to their work because they view helping people as a calling, the reality of their world today is less than idyllic. Primary care physicians today must navigate an increasingly complex and administratively burdensome environment, with shrinking decision autonomy. They are also being held accountable to a set of measures around quality and outcomes, with an ever-greater load of patients who are suffering from higher rates of chronic illness.
In the face of these challenges, the primary care market remains an important one for the pharmaceutical industry. More than half of US patient visits are to primary care physicians. Serving PCPs well, however, requires new forms of engagement, including:
- New means for listening to PCPs and understanding their varied needs and preferences;
- A multi-channel approach to engagement, information sharing and education that is easy to navigate on-demand;
- A focus on sharing real-world evidence and research that will help them in their quest to deliver measurable patient outcomes;
- A “total account” approach, where we understand and interact with the entire physician practice, providing information to support NPs and PAs, and also helping the back office to eliminate unnecessary administrative burden, and;
- Equipping patients with appropriate information and education to have better dialogues with their health care professionals.
Takeda and our partners have taken a number of creative approaches to addressing these challenges, and to adapting to the evolving needs of primary care. Takeda’s US President, Ramona Sequeira, will share some key insights and innovative examples from Takeda’s journey to continue to effectively serve this important market.
About the Author:
Ramona Sequeira, President, Takeda Pharmaceuticals (United States Business Unit), is responsible for the company’s commercial operations in the U.S. With almost thirty years of experience in the field, she serves as a member of Takeda’s Executive Team.
Ramona Sequeira will also be speaking at this year's annual PSA: The Pharmaceutical Strategy Conference in New York City. Want to hear what else Ramona has to say about effective primary care and preventative measures? Register for the event!
For $100 off use discount code: PCON16BLOG
New Technologies Transforming the World of Healthcare
Differentiating Strategies in Healthcare to Separate Yourself from the Competition
Igniting Biotech Innovation in Neurodegenerative Disorders
3 Types of Services Physician Can Use to Grow Their Private Practice
Subscribe to our newsletters and alerts!
Join the conversation on LinkedIn
Like Us on Facebook ;-)
Follow Us on Twitter